Endocrine side effects of immune checkpoint inhibitors

被引：17

作者：

Cardona, Zulma ^{[1
]}

Sosman, Jeffrey A. ^{[2
]}

Chandra, Sunandana ^{[2
]}

Huang, Wenyu ^{[1
]}

机构：

[1] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA

[2] Northwestern Univ, Div Hematol & Oncol, Feinberg Sch Med, Chicago, IL USA

来源：

FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷

关键词：

immune checkpoint inhibitor (ICI); endocrine side effects; hypophysitis; thyroiditis; type1; diabetes; adrenalitis; adrenal insufficiency; central diabetes insipidus; IPILIMUMAB-INDUCED HYPOPHYSITIS; CELL LUNG-CANCER; QUALITY-OF-LIFE; ADVERSE EVENTS; RETROSPECTIVE ANALYSIS; ADRENAL INSUFFICIENCY; THYROID ANTIBODIES; PD-1; EXPRESSION; NIVOLUMAB; MANAGEMENT;

D O I：

10.3389/fendo.2023.1157805

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Immune checkpoint inhibitors (ICIs) have increasingly been the mainstay of treatment for numerous malignancies. However, due to their association with autoimmunity, ICIs have resulted in a variety of side effects that involve multiple organs including the endocrine system. In this review article, we describe our current understanding of the autoimmune endocrinopathies as a result of the use of ICIs. We will review the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of the most commonly encountered endocrinopathies, including thyroiditis, hypophysitis, Type 1 diabetes, adrenalitis, and central diabetes insipidus.

引用

页数：12

共 50 条

[41] How we treat endocrine complications of immune checkpoint inhibitors
Paschou, S. A.
Stefanaki, K.
Psaltopoulou, T.
Liontos, M.
Koutsoukos, K.
Zagouri, F.
Lambrinoudaki, I
Dimopoulos, M-A
ESMO OPEN, 2021, 6 (01)
[42] Renal effects of immune checkpoint inhibitors
Izzedine, Hassan
Mateus, Christine
Boutros, Celine
Robert, Caroline
Rouvier, Philippe
Amoura, Zahir
Mathian, Alexis
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (06) : 936 - 942
[43] Endocrine Adverse Reactions of Tyrosine Kinase Inhibitors in Combination With Immune Checkpoint Inhibitors
Shao, Wen
Yang, Kaiwei
Lu, Difei
Gao, Ying
Zhang, Junqing
Zhang, Yang
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
[44] CNS side effects of immune checkpoint inhibitors: preclinical models, genetics and multimodality therapy
McGinnis, Gwendolyn J.
Raber, Jacob
IMMUNOTHERAPY, 2017, 9 (11) : 929 - 942
[45] Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review
Ruli, Thomas M.
Pollack, Ethan D.
Lodh, Atul
Evers, Charles D.
Price, Christopher A.
Shoreibah, Mohamed
CANCERS, 2024, 16 (11)
[46] Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects
Lombardi, Andrea
Mondelli, Mario U.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (08) : 872 - 884
[47] Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors
Farina, Antonio
Villagran-Garcia, Macarena
Ciano-Petersen, Nicolas Lundahl
Vogrig, Alberto
Muniz-Castrillo, Sergio
Taillandier, Luc
Michaud, Maud
Lefilliatre, Mathilde
Wang, Adrien
Lepine, Zoe
Picard, Geraldine
Wucher, Valentin
Dhairi, Maroua
Fabien, Nicole
Goncalves, David
Rogemond, Veronique
Joubert, Bastien
Honnorat, Jerome
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (01):
[48] Letter in response to 'Myositis and neuromuscular side- effects induced by immune checkpoint inhibitors'
Leclair, Valerie
Landon-Cardinal, Oceane
Hudson, Marie
EUROPEAN JOURNAL OF CANCER, 2019, 112 : 47 - 48
[49] Checkpoint Inhibitors The Diagnosis and Treatment of Side Effects
Heinzerling, Lucie
de Toni, Enrico N.
Schett, Georg
Hundorfean, Gheorghe
Zimmer, Lisa
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2019, 116 (08): : 119 - +
[50] Rare side-effects of checkpoint inhibitors
Kourie, Hampig R.
Awada, Gil
Awada, Ahmad H.
CURRENT OPINION IN ONCOLOGY, 2016, 28 (04) : 295 - 305

← 1 2 3 4 5 →